FAQs: What you need to know about the Alzheimer’s drug Aduhelm

The Food and Drug Administration on Monday approved Biogen’s new Alzheimer’s drug, a decision with far-reaching implications for patients, clinicians, and others. Here’s a rundown on some basic questions and answers about the drug, known as Aduhelm.

Who can get the drug?

The drug is approved for patients with early-stage Alzheimer’s who are experiencing mild cognitive impairment. Those with advanced Alzheimer’s will not be candidates for the drug. 

Read the rest…

FAQs: What you need to know about the Alzheimer’s drug Aduhelm

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top